智通财经APP讯，雍禾医疗(02279)公布2024年业绩，收入约18.045亿元，同比增加1.5%。毛利约10.84亿元，同比增加8.7%。净亏损约2.266亿元，同比收窄58.6%。每股基本亏损为0.45元。
公告称，集团通过优化门店网络布局，战略性地关闭和整合低效门店，并将资源重新配置到核心门店，从而显著提升了运营效率。这一举措不仅增强了整体业务的稳健性，还确保了资源的有效利用，进一步巩固了公司在市场中的竞争优势。
截至2024年12月31日，该公司在全国63个城市拥有66家植发医疗机构，在上海、广州、深圳拥有8家史云逊健发机构，为中国最大及覆盖城市最广的连锁毛发医疗集团。报告期内，公司服务患者总人数逾12万人。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.